Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study to Assess Skin Irritation and Sensitization of HP-1050 Transdermal System Compared to XULANE in Healthy Adult Females

NCT04624867 is registered in ClinicalTrials.gov with Noven Pharmaceuticals, Inc. as lead sponsor.

NCT NCT04624867
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04624867 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study to Assess Skin Irritation and Sensitization of HP-1050 Transdermal System Compared to XULANE in Healthy Adult Females
Lead sponsor
Noven Pharmaceuticals, Inc.
Phase
Phase 1
Overall status
Unknown status
Start date
November 3, 2020
Completion date
January 31, 2022
Enrollment
240 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cumulative irritation and sensitization